Brazil approves world's first single-dose dengue vaccine

news18.com

Brazil approved the world's first single-dose dengue vaccine, Butantan-DV, showing 91.6% efficacy. The vaccine, developed by the Butantan Institute, is for ages 12-59 and aims to combat soaring global dengue cases attributed to climate change. This approval comes as 2024 saw record global dengue cases, with Brazil securing 30 million doses for delivery in late 2026.


With a significance score of 4.7, this news ranks in the top 2.4% of today's 31072 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: